Page 22
Notes:
conference
series
.com
Volume 6, Issue 6 (Suppl)
J Pain Relief, an open access journal
ISSN: 2167-0846
Pain Medicine 2017
October 19-20, 2017
October 19-20, 2017 San Francisco, USA
4
th
International Conference on
Pain Medicine
Advances in photobiomodulation therapy – a new paradigm in pain management
T
he advent of new generation medical-grade LED biophotonic devices for the clinical treatment of pain using
photobiomodulation therapy (PBT) is discussed. Compared to present-day LED and laser phototherapies, the device’s
advanced technology and intuitive user interface enables a physician or pain therapist unparalleled control of treatment
conditions to maximize PBT efficacy including average power control of LED brightness and temperature, sequencing
various LED wavelengths for controlling light penetration depth and mix, treatment duration to control total energy dose,
and pulse frequency control for improved tissue specificity. The importance of treatment frequency in LightMD case studies
and the possible photochemical and photobiological mechanisms for observed pulse frequency dependence on pain and
nerve inflammation is considered. In addition to advances in photonic control, a new manufacturing technology for 3D
bendable “LightPads” is described, each comprising an array of over 200 high-brightness LEDs housed in non-porous, aseptic,
hypoallergenic polymeric pads, designed to bend and fit snugly to a person’s body contours to reduce optical refraction from
epithelial tissue, maximize energy coupling, and enhance PBT efficacy. Compared to the small spot size of laser probes and
LED wands, a set of six LightPads offers hands-free treatment of injured or painful tissue 300 times the area of conventional
probes. The professional medical PBT device is FDA audited and approved in United States, Taiwan, Dubai, and the United
Arab Emirates; CE and ISO-13485 medical safety rated, uses FDA-certified good manufacturing practices (GMP), and is IEC
rated for photobiological safety (no glasses required). A sneak peek of a lower cost “prosumer” (professional-consumer) device
will also be provided
Biography
Richard is a serial entrepreneur, technologist, author, speaker, and prolific inventor. Currently he is CEO, President, and Chief Technology Officer (CTO) of Applied
BioPhotonics Ltd., a Hong Kong based medical-device design specifier and GMP-certified manufacturing company, and is CEO of LightMD Inc., a Silicon Valley
based seller of photobiomodulation therapy (PBT) devices. In 1999, he founded Advanced Analogic Technologies, and as CEO-CTO developed the first LED
backlight dimming and LED camera flash for smartphones, followed by dynamic LED backlighting for major brand HDTVs.
richardwilliams@LightMD.comRichard KWilliams
LightMD & Applied BioPhotonics, USA
Richard K Williams, J Pain Relief 2017, 6:6 (Suppl)
DOI: 10.4172/2167-0846-C1-016